Pharma/fine chemicals roundup—20 November

Teva’s API business reports rise in sales Teva Pharmaceutical Industries (Petach Tikva, Israel), which has the largest active pharmaceutical ingredient (API) business in the world in terms of sales, recorded a 6.6% rise in API sales in the third quarter ended 30 September 2012, compared with the year-ago quarter, to $195 million. In the first nine months of 2012, Teva’s sales from the API business increased 8%, compared with the first nine months of 2011, to $594 million. Report: API market in Asia/Pacific to reach $63.8 billion by 2017 The total...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers